Jun Ko

Jun Ko


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2024 in Materials Today Bio
Verified
Journal Article
Open access
QXQiaxin Xu
Qiaxin Xu
ZXZeyu Xiao
Zeyu Xiao
QYQianzhi Yang
Qianzhi Yang
TYTingting Yu
Tingting Yu
XDXiujiao Deng
Xiujiao Deng
JWJinghao Wang
Jinghao Wang
A life-threatening illness that poses a serious threat to human health is myocardial infarction. It may result in a significant number of myocardial cells dying, dilated left ventricles, dysfunctional heart function, and ultimately cardiac failure. Based on the development of emerging biomaterials and the lack of clinical treatment methods and cardiac donors for myocardial infarction, hydrogels with good compatibility have been gradually applied to the treatment of myocardial infarction. Specifically, based on the three processes of pathophysiology of myocardial infarction, we summarized various types of hydrogels designed for myocardial tissue engineering in recent years, including natural hydrogels, intelligent hydrogels, growth factors, stem cells, and microRNA-loaded hydrogels. In addition, we also describe the heart patch and preparation techniques that promote the repair of MI heart function. Although most of these hydrogels are still in the preclinical research stage and lack of clinical trials, they have great potential for further application in the future. It is expected that this review will improve our knowledge of and offer fresh approaches to treating myocardial infarction.


14 January 2024 in Pharmacological Research
Verified
Journal Article
Open access
RLRuixue Liu
Ruixue Liu
FLFengjuan Li
Fengjuan Li
SHShuai Hao
Shuai Hao
DHDongyao Hou
Dongyao Hou
XZXue Zeng
Xue Zeng
CDChenyang Duan
Chenyang Duan
Sepsis is a dysregulated response to infection that can result in life-threatening organ failure, and septic cardiomyopathy is a serious complication involving ferroptosis. Olaparib, a classic targeted drug used in oncology, has demonstrated potential protective effects against sepsis. However, the exact mechanisms underlying its action remain to be elucidated. In our study, we meticulously screened ferroptosis genes associated with sepsis, and conducted comprehensive functional enrichment analyses to delineate the relationship between ferroptosis and mitochondrial damage. Eight sepsis-characterized ferroptosis genes were identified in sepsis patients, including DPP4, LPIN1, PGD, HP, MAPK14, POR, GCLM, and SLC38A1, which were significantly correlated with mitochondrial quality imbalance. Utilizing DrugBank and molecular docking, we demonstrated a robust interaction of Olaparib with these genes. Lipopolysaccharide (LPS)-stimulated HL-1 cells and monocytes were used to establish an in vitro sepsis model. Additionally, an in vivo model was developed using mice subjected to cecal ligation and perforation (CLP). Intriguingly, low-dose Olaparib (5mg/kg) effectively targeted and mitigated markers associated with ferroptosis, concurrently improving mitochondrial quality. This led to a marked enhancement in cardiac function and a significant increase in survival rates in septic mice (p < 0.05). The mechanism through which Olaparib ameliorates ferroptosis in cardiac and leukocyte cells post-sepsis is attributed to its facilitation of mitophagy, thus favoring mitochondrial integrity. In conclusion, our findings suggest that low-dose Olaparib can improve mitochondrial quality by accelerating mitophagy flux, consequently inhibiting ferroptosis and preserving cardiac function after sepsis.

24 February 2024 in Leukemia
Verified
Journal Article
Closed access
PDF file
WYWeiwei Yi
Weiwei Yi
JZJinhua Zhang
Jinhua Zhang
YHYingxin Huang
Yingxin Huang
QZQiang Zhan
Qiang Zhan
MZMi Zou
Mi Zou
ZCZhiyang Chen
Zhiyang Chen

24 September 2024 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
FLFeng-Juan Li
Feng-Juan Li
HHHuantao Hu
Huantao Hu
LWLiangyan Wu
Liangyan Wu
BLBijun Luo
Bijun Luo
YZYuan Zhou
Yuan Zhou
HPHu Peng
Hu Peng

14 July 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
SCSiyuan Cheng
Siyuan Cheng
YHYuchen Han
Yuchen Han
LJLie Jiang
Lie Jiang
ZLZiyin Lan
Ziyin Lan
HLHuanyan Liao
Huanyan Liao
JKJun Ko
Jun Ko
Objective Evidence on the association of oxidative balance score (OBS) and visceral adiposity index (VAI) with risk of ischaemic heart disease (IHD) is limited. We aimed to explore the association of OBS and VAI with risk of IHD, and then examined their potential interactive effects. Design A cross-sectional study. Setting The National Health and Nutrition Examination Survey. Participants A total of 27 867 individuals aged more than 20 years were included in this study. Primary and secondary outcome measures Multivariable logistic regression analyses were used to estimate ORs and 95% CIs for the associations of OBS and VAI with risk of IHD, including coronary heart disease (CHD), heart attack and angina pectoris. Results Compared with those in the first quintile, participants with highest quintile of OBS had decreased risk of IHD (OR: 0.59, 95% CI: 0.50, 0.69), CHD (OR: 0.65, 95% CI: 0.52, 0.80), heart attack (OR: 0.53, 95% CI: 0.43, 0.66) and angina pectoris (OR: 0.63, 95% CI: 0.48, 0.82); meanwhile, those with highest quintile of VAI had increased risk of IHD (OR: 1.46, 95% CI: 1.22, 1.74), CHD (OR: 1.34, 95% CI: 1.07, 1.67), heart attack (OR: 1.55, 95% CI: 1.24, 1.94) and angina pectoris (OR: 1.40, 95% CI: 1.04, 1.87). Furthermore, we observed a stronger association between OBS and risk of IHD among participants with VAI ≥1.73 (OR: 0.50, 95% CI: 0.40, 0.62). Conclusion Our study found the negative association between OBS and risk of IHD, and positive association between VAI and risk of IHD. In addition, we found the interactive effects between VAI and OBS on the risk of IHD, underlining the importance of OBS in IHD prevention among participants with high VAI level.